4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell LymphomaB-cell chronic lymphocytic leukemia, B-cell neoplasm, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, diffuse large B-cell lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasmActive, not recruitingPhase 1 / Phase 22026-10-06NCT03625037
Pathophysiological Explorations of Red Blood Cellserythrocyte disorderRecruitingNot stated2026-09-09NCT03541525
Glofitamab in Real Lifelarge B-cell lymphomaRecruitingNot stated2026-06-03NCT06994169
Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple SclerosisCNS demyelinating autoimmune disease, Charcot-Marie-Tooth disease type 1F, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorderRecruitingNot stated2024-05-14NCT03981003